Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | President and COO | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 185,088 |
Reported balance
After 2026-10-02 transaction · row 1
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 25,714 · Balance 185,088 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 23, 2025 Filed Jul 25, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,232 | $35.74 | $79,773.91 |
DisclosureSEC source: 0001214659-25-010924 · marketforms-70132.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,342 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 209 | $36.19 | $7,564.34 |
DisclosureSEC source: 0001214659-25-010085 · marketforms-70056.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,574 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,877 | $29.75 | $55,835.12 |
DisclosureSEC source: 0001214659-25-008300 · marketforms-69625.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,783 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 20,000 | $32.31 | $646,260.00 |
DisclosureSEC source: 0001214659-25-007405 · marketforms-69404.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,660 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $31.845 to $32.76 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,800 | $37.65 | $105,422.80 |
DisclosureSEC source: 0001214659-25-007103 · marketforms-69368.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,660 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,058 | $40.00 | $82,309.71 |
DisclosureSEC source: 0001214659-25-006403 · marketforms-69200.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,460 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 206 | $38.73 | $7,979.00 |
DisclosureSEC source: 0001214659-25-005459 · marketforms-69099.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,518 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,839 | $44.18 | $81,241.50 |
DisclosureSEC source: 0001214659-25-003437 · marketforms-68341.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,724 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,845 | $49.35 | $140,406.44 |
DisclosureSEC source: 0001214659-25-002007 · marketforms-67968.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,199 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,422 | $50.17 | $121,500.60 |
DisclosureSEC source: 0001214659-25-001369 · marketforms-67911.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,044 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 229 | $45.59 | $10,440.36 |
DisclosureSEC source: 0001214659-25-000309 · marketforms-67751.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,466 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 53,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-020032 · marketforms-67493.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,695 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 22:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 10,340 | $48.00 | $496,299.32 |
DisclosureSEC source: 0001214659-24-018894 · marketforms-67322.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,061 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,239 | $44.61 | $278,290.60 |
DisclosureSEC source: 0001214659-24-018613 · marketforms-67290.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,401 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 06, 2024 Filed Nov 15, 2024 21:05 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,239 | $44.61 | $278,290.60 |
DisclosureSEC source: 0001214659-24-019250 · marketforms-67365.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,401 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,681 | $41.56 | $111,433.08 |
DisclosureSEC source: 0001214659-24-018499 · marketforms-67272.xml · nonDerivative · entry 4 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,640 F2 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 23,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-018499 · marketforms-67272.xml · nonDerivative · entry 3 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,321 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 27,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-018499 · marketforms-67272.xml · nonDerivative · entry 2 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,770 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-018499 · marketforms-67272.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,483 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| October 23, 2024 Filed Oct 25, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,261 | $43.09 | $97,428.75 |
DisclosureSEC source: 0001214659-24-017945 · marketforms-67179.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,483 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,865 | $43.21 | $296,643.52 |
DisclosureSEC source: 0001214659-24-017192 · marketforms-67120.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,744 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,885 | $39.93 | $115,186.51 |
DisclosureSEC source: 0001214659-24-014032 · marketforms-66735.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,327 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| July 23, 2024 Filed Jul 25, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,207 | $56.63 | $124,971.38 |
DisclosureSEC source: 0001214659-24-012973 · marketforms-66652.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,212 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 476 | $48.00 | $22,848.95 |
DisclosureSEC source: 0001214659-24-012023 · marketforms-66497.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,419 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,311 | $37.13 | $85,816.67 |
DisclosureSEC source: 0001214659-24-008520 · marketforms-65755.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,895 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,174 | $30.12 | $65,483.05 |
DisclosureSEC source: 0001214659-24-007561 · marketforms-65614.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,206 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 492 | $32.74 | $16,106.11 |
DisclosureSEC source: 0001214659-24-006124 · marketforms-65454.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,380 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,626 | $36.59 | $96,085.34 |
DisclosureSEC source: 0001214659-24-002003 · marketforms-64519.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,140 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,383 | $34.76 | $82,833.08 |
DisclosureSEC source: 0001214659-24-001145 · marketforms-64371.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,766 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 382 | $36.86 | $14,080.52 |
DisclosureSEC source: 0001214659-24-000250 · marketforms-63986.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,149 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 21:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,028 | $24.74 | $25,432.72 |
DisclosureSEC source: 0001214659-23-015501 · marketforms-63579.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,531 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 79,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-014605 · marketforms-63439.xml · nonDerivative · entry 3 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,559 F3 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 4,158 | $17.31 | $71,974.98 |
DisclosureSEC source: 0001214659-23-014605 · marketforms-63439.xml · nonDerivative · entry 2 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,774 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 19,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-014605 · marketforms-63439.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,932 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 306 | $16.58 | $5,073.48 |
DisclosureSEC source: 0001214659-23-013922 · marketforms-63415.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,189 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 20, 2023 Filed Oct 24, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,176 | $16.75 | $36,448.00 |
DisclosureSEC source: 0001214659-23-013840 · marketforms-63412.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,495 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 457 | $20.26 | $9,258.82 |
DisclosureSEC source: 0001214659-23-013058 · marketforms-62721.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,671 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,028 | $19.46 | $20,004.88 |
DisclosureSEC source: 0001214659-23-011601 · marketforms-62259.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,128 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 306 | $25.09 | $7,677.54 |
DisclosureSEC source: 0001214659-23-010004 · marketforms-62115.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,007 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,176 | $25.11 | $54,639.36 |
DisclosureSEC source: 0001214659-23-009947 · marketforms-62114.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,313 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 457 | $20.46 | $9,350.22 |
DisclosureSEC source: 0001214659-23-009244 · marketforms-62018.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,489 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,027 | $13.03 | $13,381.81 |
DisclosureSEC source: 0001214659-23-007733 · marketforms-61594.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,946 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 306 | $13.63 | $4,170.78 |
DisclosureSEC source: 0001214659-23-005944 · marketforms-61305.xml · nonDerivative · entry 2 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,973 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,176 | $13.75 | $29,920.00 |
DisclosureSEC source: 0001214659-23-005944 · marketforms-61305.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,279 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 457 | $15.08 | $6,891.56 |
DisclosureSEC source: 0001214659-23-004683 · marketforms-61121.xml · nonDerivative · entry 2 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,455 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,176 | $27.03 | $58,817.28 |
DisclosureSEC source: 0001214659-23-004683 · marketforms-61121.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,912 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,027 | $22.52 | $23,128.04 |
DisclosureSEC source: 0001214659-23-002911 · marketforms-59580.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,532 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 30,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001653 · marketforms-59308.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,559 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 22, 2022 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 337 | $28.74 | $9,685.38 |
DisclosureSEC source: 0001214659-23-001161 · marketforms-58284.xml · nonDerivative · entry 1 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,933 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 220 | $23.81 | $5,238.20 |
DisclosureSEC source: 0001214659-23-000270 · marketforms-57984.xml · nonDerivative · entry 2 Finn Patrick John · CIK 0001755970 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,270 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.